PTEN and cancer: PI3K signaling is one of the most frequently aberrantly activated pathways in cancer, mainly including activating mutation of PIK3CA and loss-of-function mutation of PTEN. 15Interestingly, the TCGA studies found that PIK3CA is the most frequently mutated kinase, with 17% of human cancers harboring a PIK3CA mutation.16